(VRCA) |
| 0 (0%) 10-10 04:03 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 5.29 |
| Resistance 1: | 4.78 |
| Pivot price: | 4.39 |
| Support 1: | 3.96 |
| Support 2: | 3.29 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -7.740 |
| Book Value | -1.890 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.530 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 11.89 |
| Return on Assets (ttm) | -51.9 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 09 Oct 2025
What candlestick patterns are forming on VRCA - Trade Analysis Summary & Weekly Top Performers Watchlists - newser.com
Tue, 07 Oct 2025
12‑Week Immune Activation: Verrica Presents Phase 2 VP-315 Tumor Microenvironment Data at SITC - Stock Titan
Mon, 06 Oct 2025
What drives VRCA stock price - Institutional Buying Trends & Grow Generational Wealth With Ease - earlytimes.in
Wed, 24 Sep 2025
‘One of the most competitive yet’: VRCA’s 36th annual Gold Awards of Excellence winners - constructconnect.com
Fri, 19 Sep 2025
Verrica Pharmaceuticals (VRCA) Gains Approval for YCANTH in Japa - GuruFocus
Fri, 19 Sep 2025
$10M Milestone Achievement: Verrica's Molluscum Drug YCANTH Receives Landmark Japan Approval via Torii - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
